,21 In the real-world setting, a previous study reported neutropenia (13.2%) and gastrointestinal upset (10.5%) as the most common treatment toxicities when combining EGFR TKI with crizotinib.25 The gene discussed is EGFR; the disease is Decreased total neutrophil count.